Cleveland, OH, United States of America

Edward V Maytin

This inventor holds 1 USPTO granted patent. Top assignee: Sun Pharmaceutical Industries Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward V Maytin. Retrieved from https://idiyas.com/inventor/edward-v-maytin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward V. Maytin: Inventor in Photodynamic Therapy

Introduction

Edward V. Maytin is an inventor associated with Cleveland, Ohio, and Sun Pharmaceutical Industries Limited. His patent work addresses reducing pain during photodynamic therapy for actinic keratosis, a skin condition treated with this therapy.

Latest Patents

Maytin is credited with 1 patent: “Methods for Reducing Pain During Photodynamic Therapy of Actinic Keratosis.” The invention describes methods for reducing pain during the therapy and treating actinic keratosis while minimizing treatment-related pain.

Career Highlights

A key highlight of Maytin’s documented innovation work is his patent focused on improving the experience of patients undergoing photodynamic therapy. The supplied information associates him with Sun Pharmaceutical Industries Limited.

Collaborations

The available information identifies Sun Pharmaceutical Industries Limited as the company associated with Maytin. No additional collaborators are specified in the provided details.

Conclusion

Edward V. Maytin’s patent focuses on reducing pain during photodynamic therapy for actinic keratosis, reflecting an effort to make treatment more tolerable for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…